Nach Genre filtern

LET'S TALK PLANT MEDICINE: Cannabis, Psychedelics & Pharmaceutics with Dr. O

LET'S TALK PLANT MEDICINE: Cannabis, Psychedelics & Pharmaceutics with Dr. O

Lola Ohonba
Bildung, Gesundheit

This show is for educational purposes and should not be taken as medical advice, Dr. O is a clinical pharmacist certified in medical cannabis. In this podcast, you will learn about alternative ways to improve your health and well-being using the healing power of medicinal herbs such as cannabinoids, psychedelics, and conventional therapy.

120 - #61 How Cannabis Can Be Effective for Cancer Pain
0:00 / 0:00
1x
  • 120 - #61 How Cannabis Can Be Effective for Cancer Pain

    "Dr. Worcester On The Role Of Big Pharma In Cannabis Research & Education For Cancer Pain Management"

    Summary/Abstract

    Dr. Brooke Worster is the Chief Medical Advisor at Ethios and a cancer pain specialist. She is also a cannabis researcher at Thomas Jefferson University in Pennsylvania. On the show, she discussed her background in pain management and how she got interested in cannabis research. She explained how cannabis is often recommended to her patients, either by their family members, caregivers, or friends. However, the medical community doesn't pay much attention to the positive side of cannabis. She is working to change that and to provide more resources to people interested in cannabis.

    Dr. Jeffrey Gendelman discussed his experience with medical cannabis, which began when he felt like he had to respond to patients' questions with I don't know as he had not done much research on the subject. However, when the Pennsylvania legislature passed legislation allowing academic medical centers to partner with vertically integrated growth, production, and dispensing companies, he decided to take the initiative and learn more.

    Dr. Gendelman noted the disconnect between patients and providers when it comes to cannabis; patients often feel uncomfortable bringing it up and providers rarely initiate the dialogue due to a lack of knowledge. He believes it's important for doctors, particularly oncologists, to learn how to talk to their patients about cannabis in order to bridge this gap.

    The conversation is about how healthcare professionals are not engaging with cannabis as a treatment option. The speaker notes that only a quarter of 10,000 cancer patients feel comfortable talking to their physicians about cannabis. The stigma and hysteria surrounding cannabis have made some patient groups reluctant to even bring up the topic with their physician. The speaker wonders why the medical community has not embraced the potential of cannabis as a therapy, given its long history of use in medicine. He argues that access to and use of cannabis is increasing, and medical professionals must pay attention to it. He also notes that research into the potential of cannabis as a therapy has been limited due to restrictions on its use. The speaker suggests healthcare professionals must become more educated about cannabis and its potential therapeutic uses.

    There is not enough education and training available for healthcare professionals to bridge the gap in knowledge around cannabis. This lack of accessible education means that professionals have to do their own research and digging to gain knowledge. It is important to talk to patients and hear their experiences, although it is not the same as a randomized clinical trial. To gain more knowledge and bridge the gap, healthcare professionals should make some noise about the educational gap and try to get more educational outreach and efforts happening.

    Timestamps

    0:00:06

    Conversation with Dr. Brooke Worster, Chief Medical Advisor at Ethios and Cancer Pain Specialist

    0:03:01

    Exploring the Disconnect between Patients and Providers on Cannabis Use

    0:05:30

    Exploring the Disconnect Between Clinicians and Cannabis Use in Cancer Patients

    0:10:48

    Discussion on Accessible Education for Healthcare Professionals on Cannabis Use

    0:13:10

    Heading: Dr. Worcesters Discusses the Legalization of Medical Cannabis and Dispels the Myth of Losing Licenses

    0:16:02

    Heading: Discussion on the Role of Big Pharma in Cancer Pain Management with Dr. Worcester

    0:20:23

    Heading: The Power of Plant-Based Medicines in Treating Cancer Pain and Nausea

    0:22:35

    Discussion on the Need for Standardized Cannabis Labeling Systems

    0:26:13

    Conversation on Standardizing Cannabis Information for Patients

    0:28:15

    Heading: Exploring Cannabis Use in Healthcare: A Conversation with Dr. Worcester

    0:30:17

    Interview with Dr. Lola Wasa: Exploring the Benefits of Cannabis Medicine

    Highlights

    Finally, Dr. Worcester, I have another of your quote. You said, the patient knows this stuff. They are reading it online and hearing from friends, but they are also getting a lot of disinformation and bad advice from this. We as a medical community need to step up, embrace these resources that patients are using, whether they are in a legal state, use or not, and provide some guidance. What else can we do in the community, especially in the healthcare space, to make sure patients are getting evidence-based data?

    I think it would go a long way if we even kind of got our act together enough to have a standardized labeling system for cannabis for products. Right. Because the way that they're labeled is all different from state to state and how it's kind of shown concentration versus percentage of various cannabinoids versus ratios. That's confusing to patients. So I think one thing that I would say could be changed that would kind of a little bit come from the dispensary and the legislative side that wouldn't require a ton of work, but would just be to say kind of like we do for other nutraceuticals or over the counter products is like you have to have certain labeling standards. The way that you say what's in it is the same.

    We can make you make sense of what doesn't make sense folks. Dr. Worcester, Dr. O can help you make sense, of what doesn't make sense. Now let's go back to our patient. Dr. Worcester, in one of your call recently, you said many patients are simply guessing and doing their best at both adult use and even for medical purposes. They go to the Dispensaries or go online and just try to figure it out. He said the evidence is strong that cannabis is effective for cancer pain. It's also very likely effective for nausea, cancer-related nausea, and vomiting, which is what we are part of what we are using dronabinol for.

    And I totally agree with you that what is there to lose? They have more to gain because even right now when we talk about chronic conditions like cancer, it's like all hands on deck. Back in the day we never used to use lidocaine patches to manage cancer pain. Now we are able to dispense the patches for neuropathic pain, and cancer-related neuropathic pain for our patients. So it's all hands on deck. Pain is pain. Pain is not going to be okay. It's just narcissistic pain.

    And I do tell people, you are the expert when it comes to cancer pain management. During my rotation, I did do some cancer rotation. I do tell patients, cancer patients in particular, when you see them going through pain, some of them, you don't even know the level of pain they're going through. Somebody can be looking at you off-screen, and their pain is ten because they've developed a system to cope with pain management in such a way that acute pain might not be the same. I might just cut my finger and start screaming the whole place down whereby somebody sitting by me is going through a critical condition like cancer. What is the part of the big farmer? I know that Big Pharma probably just doesn't even want anything to be approved, considering the level of money that is being generated from that space.

    Wed, 01 Feb 2023
  • 119 - #60 How Lumenate Is the App "Tat Makes You Trip"

    Lumenate is a pioneering app that uses sound and light to change brain rhythms in ways similar to psychedelics and highly experienced meditators, and brain imaging researchers at Imperial College London and as well as researchers in Berlin. 

    Our guests have talked about what psychedelic experiences and Lumenate appear to have in common. They talked about Increased brain signal complexity, reduced activity in the default mode network, increased functional connectivity between different brain regions, and reductions in peak alpha brainwaves. 

    They have ongoing trials underway in London which "aims to uncover neural mechanisms of visual imagery induced by Lumenate, using high-density EEG. The research also aims at comparing psychedelic experiences induced by DMT and Lumenate, by exploring the psychological and biological mechanisms of both altered states of consciousness”.

    Thu, 19 Jan 2023
  • 118 - #59 Transitional Cannabis Research and Clinical Trials

    Dr. Cornblatt is a Johns Hopkins University School of Medicine Graduate with a Ph.D. in Pharmacology and Molecular Sciences and a postdoctoral fellowship from the Johns Hopkins Bloomberg School of Public Health, Environmental Health Sciences Division of Toxicology.

    Dr. Cornblatt has served as Director of Consumer Clinical Research and Science and as Medical Director at Nutramax Laboratories Consumer Care, Inc. In this role, Dr. Cornblatt developed novel nutraceutical formulations, designed both in vitro and clinical studies in support of products, and summarized both supporting laboratory and clinical research for healthcare workers and consumers.

     His most recent development has been a novel line of products (and 18 related clinical trials) that deliver the essential ingredients needed to support the production of sulforaphane, a phytochemical with many emerging indications. Dr. Cornblatt is also the inventor of three issued patents and four pending provisional patents focused on plant-based bioactive compounds and health promotion.

    Wed, 04 Jan 2023
  • 117 - #58 Psychedelic Treatment over Traditional Therapeutics?

    Silo Pharma merges traditional therapeutics with psychedelic research to develop innovative solutions that address a variety of underserved conditions including Alzheimer’s, Fibromyalgia, Parkinson’s, Multiple Sclerosis (MS), Rheumatoid Arthritis (RA), as well as stress-induced psychiatric disorders (i.e. PTSD) and other debilitating chronic conditions. We talk about the research and the conditions you choose to study in conjunction with psychedelic treatment. 

    Silo has partnered with several leading academic institutions (the University of California, San Francisco, Columbia University, and the University of Maryland, Baltimore) to facilitate a streamlined regulatory pathway for drug approval. The company has developed a pipeline of proprietary licensed therapeutics that show promise for a range of illnesses and diseases.

    Silo Pharma Inc. has begun dosing in its IND-enabling study of a proprietary time-released, topical formulation of ketamine SP-26 designed to treat fibromyalgia. The safety evaluation trial will be conducted by Experimur, a Frontage Company, and intends to evaluate the tolerability of SP-26 to establish a maximum dose in the treatment of this chronic medical condition causing widespread musculoskeletal pain as well as memory issues, sleep difficulties, and fatigue.

    Wed, 28 Dec 2022
  • 116 - #57 Psychedelic Integration, Mastering Change and The Shadow Tribe

    Steven Twohig has been studying an abundance of practices extensively, including mindfulness, business optimization, shadow work and facilitation, Neuro-Linguistic Programming (NLP), hypnotherapy, and leadership dynamics. He recently has been researching psychedelic integration, which is defined as a process in which the patient integrates the insights of their experience into their life, and PHRI is a method of supporting that in the clinical consultation room.

    On Steven's website for Mastering Change, he wrote: “miscoding deep in the human mind. This coding is the root cause of all suffering in the world. By doing your shadow work, you are doing the work necessary to change the world. Everything in this reality is a reflection of everything else. If above, so below. So within, so without. You are a reflection of your outside world, just like this world is a reflection of you.” Steven expands on this and much more in today's episode. 

    Wed, 21 Dec 2022
Weitere Folgen anzeigen

Podcasts ähnlich wie LET'S TALK PLANT MEDICINE: Cannabis, Psychedelics & Pharmaceutics with Dr. O